BECOME A SVJ PUBLISHER
& publish your company news
favicon

Eligo Bioscience Raies $30M Series B for its microbiome gene-editing technology

Eligo Bioscience, a pioneering gene-editing company based in France, has successfully raised $30 million in a Series B funding round, with Sanofi Ventures…

Biotech /

December 9, 2023